IGF2 and esophageal cancer: Studies have shown that miR-454-3p overexpression can inhibit the expression of insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) at the protein and mRNA expression levels and thus inhibit the occurrence and development of esophageal cancer (Yan et al., 2020).